Project evolution
REVERT focuses on an innovative AI-based decision support system utilizing the experience and real-world data from several European general hospitals.
The main goal is to develop an improved and innovative model of combinatorial therapy that identifies the most efficient and cost-effective therapeutic intervention for patients with unresectable mCRC
- 7 medical oncology units involved in the clinical trials
- 1 Predictive algorithm ‘trained’ through retrospective evaluation of the clinical profiles of patients
- Detailed analysis based on the study of consolidated data – which have been classified in the Revert database – on metastatic patients from European biobanks
Project preparatory phase:
- Develop the comprehensive financial management framework for the lead partner and assist with the overall Grant and Consortium Agreement closing process
- Support the set up of a Joint Research Unit
Project implementation:
- Permanently align budget and operations
- Financial Reporting & Amendments management
- Monitor clinical studies, assess technoloygy readiness of the platform and identify follow-up opportunities
CONTACT US TODAY
Let's get in touch
Are you ready for a better, more productive business?
